# Bioinformation Therapy for Intestinal Cancer

> **NCT03350490** · PHASE2,PHASE3 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 120 (actual)

## Conditions studied

- Advanced Intestinal Cancer

## Interventions

- **DEVICE:** Cancer ablation
- **DRUG:** Life information rehabilitation therapy

## Key facts

- **NCT ID:** NCT03350490
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350490, "Bioinformation Therapy for Intestinal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03350490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*